Investors Aspect Ratio 1200 480

Investors Overview

Corporate Profile

Vor Bio is a clinical-stage cell and genome engineering company that aims to change the standard of care for patients with blood cancers by engineering hematopoietic stem cells to enable targeted therapies post-transplant.

Latest Events

September 11, 2024 at 10:50 AM EDT
September 5, 2024 at 4:30 PM EDT

Stock Quote

Symbol :

Stock Chart

Minimum 15 minutes delayed. Source: